Kiromic Biopharma, Inc. Indemnification Agreements
3 Contracts & Agreements
- Indemnification Agreement effective as of February 14, 2022, by and between Kiromic BioPharma, Inc. and Daniel Clark (Filed With SEC on February 16, 2022)
- Indemnification Agreement effective as of January 27, 2022 by and between Kiromic BioPharma, Inc. and Pietro Bersani (Filed With SEC on February 2, 2022)
- Form of Director Indemnification Agreement, to be effective upon initial public offering, between Kiromic BioPharma, Inc. and all independent directors (Filed With SEC on June 26, 2020)
